1-1 of 1
Anas Young
Close
Sort by
Journal Articles

Phase I Dose-Escalation Trial of BI 2536, a Polo-Like Kinase 1 Inhibitor, in Relapsed and Refractory Non-Hodgkin’s Lymphoma

Julie M. Vose, Anas Young, Jonathan W. Friedberg, Edmund K. Waller, Bruce D. Cheson, Dirk Trommeshauser, Gerd Munzert
Journal: Blood
Blood (2008) 112 (11): 233.
https://doi.org/10.1182/blood.V112.11.233.233
Published: 2008